Indo US Bio-Tech Appoints Mrs. Hemanshi Darsh Soni as Independent Director

Indo US Bio-Tech Limited has announced the appointment of Mrs. Hemanshi Darsh Soni as Additional Director in the capacity of Non-Executive Independent Director. The appointment was formalized through a board resolution passed on 21.04.2026, pursuant to the provisions of the Companies Act, 2013 and SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Appointment Details

The company's board has appointed Mrs. Hemanshi Darsh Soni (DIN: 11659183) for a period of 5 years effective from 21.04.2026. The appointment is subject to approval of shareholders in the General Meeting.

Parameter:	Details
Director Name:	Mrs. Hemanshi Darsh Soni
DIN:	11659183
Position:	Additional Director (Non-Executive Independent)
Appointment Date:	21.04.2026
Term:	5 years
Approval Required:	Shareholders in General Meeting

Director Profile and Independence

Mrs. Hemanshi Darsh Soni brings experience from the service sector and is recognized for building high-performance teams, implementing strong sales, marketing and service networks, and establishing robust operational processes. The company has confirmed that she is not related to any of the existing directors or key managerial personnel of Indo US Bio-Tech Limited.

Key independence criteria met:

No relationship with existing directors or key managerial personnel
Does not hold directorship in any other listed entity
Not debarred from holding director position by SEBI or any other authority

Regulatory Compliance

The appointment has been made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided all required details as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, covering appointment particulars, terms, director profile, and independence confirmations.

The appointment strengthens the company's board composition with an experienced professional from the service sector, enhancing corporate governance through independent oversight.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.15%	-2.42%	+3.25%	-26.69%	-32.63%	-64.36%

Indo US Bio-Tech Limited has announced the resignation of Mrs. Nehaben Sachinbhai Patel from her position as Non-Executive Independent Director, effective April 21, 2026. The company informed both BSE and NSE about this development on April 22, 2026, in compliance with regulatory disclosure requirements.

Director Resignation Details

Mrs. Nehaben Sachinbhai Patel, holding Director Identification Number (DIN) 09263180, submitted her resignation letter dated April 21, 2026, citing personal and unavoidable reasons for her departure from the board.

Parameter:	Details
Director Name:	Mrs. Nehaben Sachinbhai Patel
DIN:	09263180
Position:	Non-Executive Independent Director
Resignation Date:	April 21, 2026
Reason:	Personal and unavoidable reasons

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was made pursuant to Para A of Part A of Schedule III to the said Regulations and applicable SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Director's Confirmation

Mrs. Patel has provided written confirmation that there are no other material reasons for her resignation beyond those stated in her resignation letter. Additionally, she has confirmed that she does not hold directorship in any other listed entity.

Company Response

The resignation was processed with immediate effect from April 21, 2026. The company has received all necessary confirmations and documentation related to the resignation, ensuring compliance with regulatory requirements. Indo US Bio-Tech Limited acknowledged Mrs. Patel's contribution during her tenure as an Independent Director on the board.